School of Medicine
UConn-Developed Diagnostic Test for Infectious Diseases Reaches Licensing Deal
The method enables simple, rapid detection of SARS-CoV-2 and other diseases.
Provost Lejuez, Eight Other Faculty Named As Inductees to CASE
Those elected to CASE were lauded for significant contributions made to their respective fields.
Pregnant ICU Patient Recovers from COVID-19
It was the scariest time of her life for Melissa Vicchitto as she fought COVID-19 in the ICU to save herself and her unborn baby.
High-Profile Brain Tumor Therapy Trial Chooses UConn Health
An immunotherapy derived from the polio virus has shown improved survival rates in early-phase trials in patients with an aggressive type of brain tumor known as glioblastoma. UConn Health will be one of a select few sites in the U.S. for the second phase, which will pair it with the cancer immunotherapy pembrolizumab (Keytruda).
UConn Health Minute: Preventing Colon Cancer
Colon cancer is a leading cause of death in the U.S. because when it is detected late, it is very difficult to treat. Dr. Murali Dharan, director of the Advanced Endoscopy Program at UConn Health, explains that having a screening colonoscopy is an important step in prevention since it can identify and remove the polyps […]
UConn Researchers Collaborate with TIP Company Shoreline Biome to Study Microbiome in NICU
UConn researchers recently published their findings on the microbiome of premature infants in the Connecticut Children's NICU, work they completed through a collaboration with TIP company Shoreline Biome.
Podcast: Changing MS Patients’ Trajectory
The UConn Health Multiple Sclerosis Center's director and clinical care coordinator explain how the elite care of an MS center can minimize disease progression and delay the onset of disability.
Innovative Therapeutic Program Helps Those Living With PTSD
Professor Julian Ford created TARGET, an educational and therapeutic approach that explains why PTSD develops and how it can be overcome.
One-Dose Vaccine on its Way: New Tool May Arrest the Pandemic’s Progression
An Advisory Committee has just recommended the FDA grant emergency authorization use to a new, one-dose COVID-19 vaccine made by Johnson & Johnson/Janssen. Dr. Jeff Aeschlimann, Infectious Diseases Pharmacist Specialist at UConn Health and of the UConn School of Pharmacy, shares more about the third COVID-19 vaccine to be recommended for FDA-authorized emergency use, how it works differently than the other vaccines, and what new hope the single shot may bring with it.
Air Filters Can Scrub Out Air Pollutants Near Highways, Reduce Blood Pressure
Even relatively small reductions in blood pressure can affect the risk of heart attack and stroke.